Maelstrom Research Staging | SRI_Exposure_MothersA_SRIs_Neonatal

SRI_Exposure_MothersA_SRIs_Neonatal_Stress

Networks -

Variables -

Associated study SRI_Exposure Contingency Table

Population

SRI_Exposure - Cohort A Mothers taking SRIs

The population is composed of mothers who took SRIs during pregnancy at least 75 days prenatally.

Selection Criteria

Sex

Women

Pregnant Women

Second trimester

Newborns

Twins

Countries

Canada

Territory

Greater Vancouver

Ethnic Origin

Health Status

Depressed and treated with an SRI

Other Criteria

Exclusion criteria: Mothers with bipolar illnesses and/or substance abuse were excluded

Supplementary Information about selection criteria

Recruitment

Sources of recruitment

Specific population

Specific Population

Clinic patients

Supplementary Information

Participants were approached during their second trimester of pregnancy (26 weeks) from community midwife clinics, family physician clinics, and a reproductive mental health clinic in metropolitan Vancouver in British Columbia, Canada.

Number of Participants

Number of Participants: 40
Number of Participants with Biological Samples: 39
Supplementary Information about selection criteria

More info

Data Collection Event

SRI_Exposure - Cohort A Mothers taking SRIs - Neonatal Stress Study

At this time point information about general health was collected.

A blood sample and a breast milk sample was obtained for SRI levels.

More info

Collected Dataset / SRI_Exposure_MothersA_SRIs_Neonatal_Stress

SRI_Exposure_MothersA_SRIs_Neonatal_Stress

Population

SRI_Exposure - Cohort A Mothers taking SRIs

Data Collection Event

SRI_Exposure - Cohort A Mothers taking SRIs - Neonatal Stress Study

Files

Variables Classifications